Moxisylyte hydrochloride

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C16H25NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WK2KZM9V6X, chemically known as phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester) but more generally known as moxisylyte hydrochloride, which bears US NIH Compound Identifier 4260. European Medicines Agency schedules Moxisylyte hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03343MIG. Most nations, for tariff and trade purposes, schedule moxisylyte hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, MOXISYLYTE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Moxisylyte hydrochloride bears US NLM identifiers UMLS ID C1563915 and NCI Concept Code C87585. SMILES: CC1CC(C(CC1OC(=O)C)C(C)C)OCCN(C)C.CL.